| 英文摘要 |
Background: The dietary challenges and declining health associated with advanced head and neck cancer and gastrointestinal cancer often impact both the nutritional intake and overall well-being of affected patients. Additionally, the appetite status of cancer patients is known to contribute to fatigue experienced by family caregivers. Goal: This study assesses the effectiveness of intravenous fluid therapy administered during hospitalization in alleviating fatigue among family caregivers of patients with advanced head, neck, and gastrointestinal cancer, particularly those facing poor dietary intake. Methods: The study employed purposeful sampling and longitudinal structured questionnaires to investigate patients with advanced head, neck, and gastrointestinal cancers and their primary family caregivers in the Department of Hematology and Oncology at a medical center in northern Taiwan. Research instruments included a demographic questionnaire for both patients and caregivers, the ECOG Performance Status Scale, Patient-Generated Subjective Global Assessment (PG-SGA), and Brief Fatigue Inventory-Taiwan Form (BFT-T) for caregivers. Participants were enrolled from July 2018 to February 2019, completing questionnaires upon admission and after seven days of intravenous fluid therapy. Descriptive and comparative statistical analyses were conducted using SPSS 22.0. Results: The study included 155 patients, with 44 relying on tube feeding and 111 consuming food orally. Predominantly male (65.2%) and averaging 60 years old, patients exhibited ECOG scores of 0-4 and PGSGA scores of 0-12. Insufficient food intake was the primary reason for hospital admission, with 77.4% recommended intravenous fluids by their medical team. Most family caregivers were spouses (49.0%), lacked professional nursing training, were aged≥60 years (42.6%), and were predominantly women (64.5%). Statistical analysis revealed no significant difference in family caregivers' overall fatigue levels before and after the patients received seven days of infusion therapy. However, specific aspects of fatigue related to social interactions and life enjoyment were significantly worse. Conclusion: The findings suggest that hospitalization and intravenous infusion therapy for advanced cancer may not alleviate caregiver fatigue and could even have a negative impact. Future research should explore additional factors influencing caregiver fatigue in hospitalized patients with advanced head and neck cancer and gastrointestinal cancer undergoing intravenous infusion therapy. |